The global cancer supportive care product market is on track for significant growth, expected to reach US$ 68.93 billion by 2034, driven by a rising demand for effective solutions to manage treatment side effects and improve patient outcomes. The market is witnessing innovation with personalized medications, advanced drug delivery technologies, and digital health solutions.